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Objective: To investigate an outbreak of extended-spectrum beta-lactamase (ESBL)
producing Enterobacter cloacae that occurred in the Hematology ward (24-bed unit) of
the François Mitterrand University Hospital (Dijon, France) between January 2011 and
December 2013. The outbreak involved 43 patients (10 infected and 33 colonized).
Design: We performed environmental analysis to detect multiresistant E. cloacae
for comparison with clinical isolates (genotyping by pulsed-field gel electrophoresis
and MLST as well as ESBL-typing) and determined the MICs of the quaternary
ammonium compounds (QACs) alkyldimethylbenzylammonium chloride (ADBAC) and
didecyldimethylammonium chloride (DDAC). A bleach-based cleaning-disinfection
program was implemented in December 2012 after mechanical removal of the biofilm
in all sinks.
Results: We have detected 17 ESBL-producing E. cloacae in patients sink drains,
shower drains and medical sink drains. Sequencing of the bla genes performed on
60 strains recovered from patients and environment (n = 43 clinical and n = 17
environmental) revealed that bla CTX−M15 was predominant (37 isolates) followed by bla
CTX−M9 plus bla SHV−12 (20 isolates). We observed a great diversity among the isolates: 14
pulsotypes (11 STs) in clinical isolates and 9 pulsotypes (7 STs) in environmental isolates.
Six pulsotypes were identical between clinical and environmental isolates. MICs of the
quaternary ammonium compounds widely used for disinfection were very high in clinical
and environmental isolates. Immediately after the implementation of the disinfection
program we noticed a substantial fall in cases number. Our findings demonstrate the role
of drains as important reservoir of ESBL-producing E. cloacae and highlight the necessity
to settle drains accessible to achieve correct cleaning as well as to use disinfectant with
proved activity against nosocomial pathogens.
Keywords: ESBL-producing Enterobacter cloacae, outbreak, Hematology ward, contaminated sinks, quaternary
ammoniums
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INTRODUCTION
The emergence and spread of multidrug resistance among
Gram negatives is a worldwide public-health concern
limiting the therapeutic choice to treat severe community
and hospital acquired infections. Resistance to broad-spectrum
cephalosporins among Enterobacteriaceae is mostly related
to acquisition of extended-spectrum beta-lactamases (ESBLs)
(Pitout and Laupland, 2008). The epidemiology of ESBL-
producing strains has evolved: initially ESBLs were usually
TEM or SHV derivatives but since the 2000s ESBLs of CTX-M
family became predominant (Bonnet, 2004). ESBL-producers
are mostly Escherichia coli and Klebsiella pneumoniae (Tal Jasper
et al., 2015) and many outbreaks have been reported (Paterson
and Bonomo, 2005). Concerning Enterobacter cloacae the
frequency of ESBL-producers among isolates that overexpress
the chromosomal beta-lactamase is probably underestimated
(Paterson and Bonomo, 2005). Anyway there is an increasing
report of health care-associated infections due to multiresistant
isolates (Mezzatesta et al., 2012). According to Rice et al.
Enterobacter species belong to the “ESKAPE” pathogens
(Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa
and Enterobacter species) underlining the importance of this
clinical pathogen (Rice, 2008; Boucher et al., 2009). Patients who
stay in hospital for a long time are at increased risk of acquiring
an E. cloacae infection, especially those in intensive care units
(ICUs) (Wisplinghoff et al., 2004), in neonatal units (Modi et al.,
1987; Mulgrave, 1991; Dalben et al., 2008) and those suffering
from hematologic malignancy (Sanders and Sanders, 1997;
Bousquet et al., 2014).
E. cloacae infections can be acquired from endogenous
source (colonization of the gastrointestinal tract) or exogenous
sources (Chang et al., 2013). Exogenous factors include the
environment of the health care center where the patient is
hospitalized (Sanders and Sanders, 1997; Matoušková and Holy,
2014). Nevertheless the particular role of the environment in
transmission of ESBL-producing strains to patients has not been
widely investigated (Guet-Revillet et al., 2012; Gbaguidi-Haore
et al., 2013).
In this study we describe a large outbreak of ESBL-producing
E. cloacae in a Hematology ward and report the results of the
environmental investigations.
MATERIALS AND METHODS
Clinical Setting
At the time of the outbreak (January 2011-December 2013) the
Hematology ward of the teaching hospital of Dijon François
Mitterrand, France (1600 beds) included a 15-bed conventional
unit and a 9-bed unit under protective isolation. Both units were
separated with sliding doors. Each unit had a distinct nursing
room, a distinct nurse staff but shared the same medical staff. All
patients were treated for hematologic malignancies and prior to
intensive chemotherapy a central venous catheter was positioned.
Those that underwent prolonged neutropenia or bone marrow
transplantation were hospitalized in the protected area.
In the conventional unit (single rooms 3, 4, 32, 34, 36, 37, 38,
40, 41, 42, 44, 46, 48, 64, 65) there was a handbasin at the entrance
of the room for staff and visitors. Next to each room there were a
shower stall and toilets. In the 9 patient rooms under protective
isolation (single rooms 8, 10, 12, 17, 19, 20, 24, 26, 30), air was
filtered through a laminar flow system. All members of the staff
and all visitors had to wash hands in a devoted handbasin and
to wear surgical mask and gown before entering the room. A
washbasin and toilets were located next to the bed for patient use.
All taps of the ward were provided with antibacterial filters
and for hand washing the staff used mostly soap and water or
alcohol-based rinse.
Before the outbreak all surfaces surrounding the patients
used to be cleaned with a solution containing quaternary
ammonium compounds (QACs): didecyldimethylammonium
chloride (DDAC, 0.25%). This disinfectant was also daily poured
into all sinks. After hospital environment investigations had been
performed, a bleach-based cleaning-disinfection programme was
implemented in December 2012. First the biofilm was removed
from all drains (handbasins, showers, sinks) and then a bleach
solution was poured daily.
Patient Samples
This study was carried out in accordance with the
recommendations of the Ethics Committee of the University
Hospital François Mitterrand of Dijon. All subjects gave
written informed consent in accordance with the Declaration of
Helsinki. Swab throat, expectoration, urine and stool cultures
were performed weekly. Blood cultures were performed daily
(and more in case of fever). We included in the study a single
isolate per patient (the first recovered whatever the site).
Environmental Samples
In November 2012 about 100 environmental samples were
collected. Ten water samples were collected from different
taps (nursing rooms, medication preparation rooms and some
patient rooms). The water (100ml) was filtered and cultured
on Drigalski agar. For dry surfaces (beds, doors and tables) we
used Count-Tact R© agar (bioMérieux, Marcy l’Etoile, France).
We also collected 73 samples from drains. For this purpose we
introduced a sterile cotton swab to a depth of 5 cm in the drain
and performed circular sweeps. The samples were inoculated on
Drigalski agar plates supplemented with ceftazidime (4 mg/l). In
each room of the protected area we took samples from: handbasin
(drain), washbasin (drain), toilets (bowl). We also collected in
this unit a sample of the sink drain from the medication room.
In the rooms of conventional unit we analyzed drains from
handbasin, washbasin and shower.
Bacterial Identification and Antibiotic
Susceptibility Testing
Isolates were identified with API20E strips (bioMérieux, Marcy
l’Etoile, France).
Antibiogram was performed by the disc diffusion method on
Mueller–Hinton agar (bioMérieux) according to the guidelines
of the CLSI (Clinical Laboratory Standards Institute, 2012). The
production of ESBL was investigated by the double-disc synergy
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test as already described on Mueller-Hinton agar without and
with cloxacillin (250 mg/l) (Jarlier et al., 1988).
Analytical Isoelectric Focusing
After overnight culture beta-lactamases were extracted from
bacteria by sonication. Unbroken cells and cell envelopes were
removed by centrifugation. Isoelectric focusing was performed
on polyacrylamide gels containing ampholines with a pH range
of 3.5–10. The beta-lactamase activity was located on the gels by
an iodine starch procedure after overnight migration (Labia et al.,
1976).
Molecular Characterization of the ESBL
We searched for the presence of ESBL belonging to the TEM,
SHV, CTX-M, PER, and VEB families according to the results
of the pI determination. Polymerase chain reaction (PCR) and
sequencing of PCR products were performed as already described
(Siebor and Neuwirth, 2011).
Genotyping Analysis by Pulsed Field Gel
Electrophoresis (PFGE) and MLST
The genotypic analysis of the strains has been performed
by PFGE after digestion by XbaI restriction endonuclease.
Electrophoresis was carried out at 5.4 V/cm during 20 h, with
pulse-times ranging from 5 to 50 s using the CHEF-DR R©
II system (Bio-Rad). The interpretation of the results was
performed according to Tenover’s criteria (Tenover et al., 1995).
The different pulsotypes have been identified with a letter and
“Ø” indicated a pulsotype different from all patterns identified
to date in our hospital. MLST was carried out and analyzed as
previously described (Izdebski et al., 2015).
Determination of Minimum Inhibitory
Concentrations of QACs
Two compunds were chosen for this study:
alkyldimethylbenzylammonium chloride (ADBAC) and
didecyldimethylammonium chloride (DDAC) kindly provided
by Laboratoire Anios R© (Hellemmes, France). They are QACs
commonly included in products used for decontamination
of surface environment in hospital or for hand washing of
healthcare workers.
The MICs of ADBAC and DDAC were determined as
already described (Buffet-Bataillon et al., 2011) in Mueller
Hinton agar containing 0–512 mg/l of QACs. Spots (104
cfu/spot) were distributed with a replicating device (MIC
2000, Dynatech Laboratories Inc., Virginia, USA). Plates were
incubated overnight at 37◦C. The four reference strains
(Staphylococcus aureus CIP 483, Escherichia coli CIP 54127,
E. cloacae CIP 6085 and Pseudomonas aeruginosa CIP 103467)
were included to all series. We also studied 17 clinical isolates
of E. cloacae recovered in different wards of our hospital with
various profiles of resistance to beta-lactams (13 wild-type, 2
overexpression of AmpC, 2 ESBL). The MIC was defined as the
lowest concentration of QACs for which no bacterial growth was
observed. All experiments were performed in triplicate.
RESULTS
Results are summarized in Table 1 (clinical strains), Table 2
(environmental strains), and Table S1 (Supplementary data).
Outbreak
A total of 43 ESBL-producing E. cloacae have been isolated from
43 patients hospitalized in the Hematology ward between January
2011 and December 2013: 6 isolates in 2011, 25 in 2012 and
12 in 2013 (Figure 1). Most of the isolates have been recovered
from stool but also in other sites such as throat, urine, blood
(respectively 25, 8, 4, and 5) and in 1 thoracic wound (infection
of the insertion site of the central catheter). The 10 patients by
whom the ESBL-producing E. cloacae had been recovered from
urine, thoracic wound and blood harbored clinical symptoms of
infection. All other patients were considered as colonized.
Environmental Isolates
Seventeen ESBL-producing E. cloacae have been detected in
environmental samples. Most of them (16) have been recovered
in the conventional unit and only one in the protected area.
In the conventional unit the resistant organism has been found
in 9 patients rooms. All isolates have been detected in wet
environment: sink drains (medical sink drain and patient sink
drain) as well as in many shower drains.
Genotyping of the Isolates
The genotypic diversity of E. cloacae isolates is shown inTables 1,
2. The 43 strains isolated from patients belonged to 14 pulsotypes
(Figure S1) and 11 STs. Pulsotype C was the most frequently
encountered (14 strain). More than half of the isolates belonged
to ST114 or ST66. Since 2012 we observed a diversification of
the isolates with an increase in the number of pulsotypes and
the emergence of pulsotypes D and F. Isolates that belonged to
pulsotype C, D, or F represented 70% of all clinical isolates over
the 3 years.
Among the 17 environmental ESBL-producing E. cloacae
there were 9 distinct pulsotypes and 7 STs. Among the
9 pulsotypes, 6 were identical to those of patients isolates
(pulsotypes A, B, C, D, E, and F) with the same predominance of
pulsotypes C and F. Generally, in the rooms of conventional unit
several samples were positive with the exception of the rooms 37,
48, 64, and 65. In the room 34 the three samples were positive,
indicating a wide contamination.
Several rooms were contaminated by strains belonging to
different pulsotypes (rooms 36, 38, 46, and 65). In some samples
we identified strains belonging to different pulsotypes such as in
the shower drains of the rooms 46 and 65.
ESBL Characterization
Sequencing of the bla genes has been performed on 58 ESBL-
producing E. cloacae isolated from patients and environment.
All isolates belonging to the same genotype harbored the same
ESBL. Thirty-seven isolates belonging to pulsotype C, F, or Ø
(respectively 21, 12, and 4 strains) harbored CTX-M-15 whereas
20 isolates (belonging to various pulsotypes) harbored both
CTX-M-9 and SHV-12. One isolate (EcE10) recovered in a
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TABLE 1 | Characteristics of ESBL-producing Enterobacter cloacae isolated from patients hospitalized in the Hematology ward.
Patient
number
Strain Date of first
isolation
(dd/mm/yyyy)
Source
of first
isolation
ESBL PFGE
pulsotypea
ST Active antibioticsb ADBAC
MIC
(mg/l)
DDAC
MIC
(mg/l)
P1 EcP1 03/02/2011 Stool CTX-M-9/SHV-12 B 133 IPM, DOR, MEM, AMK,
TGC, FOF
ND ND
P2 EcP2 21/02/2011 Stool CTX-M-15 C 114 IPM, DOR, MEM, AMK, FOF ND ND
P3 EcP3 07/03/2011 Stool CTX-M-15 C 114 IPM, DOR, MEM, TGC, FOF ND ND
P4 EcP4 18/05/2011 Blood CTX-M-15 C 114 IPM, DOR, MEM, AMK, FOF ND ND
P5 EcP5 10/10/2011 Stool CTX-M-9/SHV-12 Ø 50 IPM, DOR, MEM, AMK, FOF ND ND
P6 EcP6 17/10/2011 Stool CTX-M-15 C 114 IPM, DOR, MEM, AMK, FOF ND ND
P7 EcP7 19/01/2012 Stool CTX-M-9/SHV-12 D 50 IPM, DOR, MEM, AMK ND ND
P8 EcP8 13/02/2012 Stool CTX-M-9/SHV-12 E 110 IPM, DOR, MEM, FOF 256 128
P9 EcP9 27/02/2012 Throat CTX-M-9/SHV-12 D 50 IPM, DOR, MEM, AMK, FOF 128 64
P10 EcP10 26/03/2012 Blood CTX-M-9/SHV-12 A 110 IPM, DOR, MEM, AMK,
OFX, CIP, TGC, FOF
256 128
P11 EcP11 01/05/2012 Blood CTX-M-9/SHV-12 D 50 IPM, DOR, MEM, AMK, FOF >512 512
P12 EcP12 31/05/2012 Stool CTX-M-9/SHV-12 B 133 IPM, DOR, MEM, FOF 256 128
P13 EcP13 11/06/2012 Stool CTX-M-15 F 66 IPM, DOR, MEM, AMK, FOF 128 128
P14 EcP14 18/06/2012 Stool CTX-M-15 C 114 IPM, DOR, MEM, AMK, FOF 256 128
P15 EcP15 05/07/2012 Throat CTX-M-9/SHV-12 B 133 IPM, DOR, MEM, CIP, TGC,
FOF
256 128
P16 EcP16 09/08/2012 Blood CTX-M-15 C 114 IPM, DOR, MEM, AMK, FOF 64 64
P17 EcP17 20/08/2012 Stool CTX-M-15 C 114 IPM, DOR, MEM, AMK,
TGC, FOF
256 128
P18 EcP18 23/08/2012 Throat CTX-M-9/SHV-12 Ø 50 IPM, DOR, MEM, CIP 128 64
P19 EcP19 30/08/2012 Stool CTX-M-9/SHV-12 D 50 IPM, DOR, MEM, AMK, FOF 512 512
P20 EcP20 26/09/2012 Thoracic
wound
CTX-M-15 C 114 IPM, DOR, MEM, AMK, FOF 256 128
P21 EcP21 29/10/2012 Urines CTX-M-15 C 114 IPM, DOR, MEM, FOF 256 128
P22 EcP22 08/11/2012 Stool CTX-M-15 F 66 IPM, DOR, MEM, FOF 256 128
P23 EcP23 12/11/2012 Stool CTX-M-15 Ø 45 IPM, DOR, MEM, AMK,
OFX, CIP, FOF
256 128
P24 EcP25 22/11/2012 Urines CTX-M-15 F 66 IPM, DOR, MEM, AMK, FOF 256 128
P25 EcP26 26/11/2012 Stool CTX-M-15 F 66 IPM, DOR, MEM, AMK, FOF 256 128
P26 EcP27 28/11/2012 Blood CTX-M-15 F 66 IPM, DOR, MEM, AMK, FOF 128 128
P27 EcP28 06/12/2012 Throat CTX-M-15 F 66 IPM, DOR, MEM, AMK, FOF 256 128
P28 EcP29 13/12/2012 Throat CTX-M-9/SHV-12 D 50 IPM, DOR, MEM, AMK, CIP,
FOF
128 64
P29 EcP30 13/12/2012 Throat CTX-M-15 F 66 IPM, DOR, MEM, AMK, FOF 256 128
P30 EcP31 17/12/2012 Stool CTX-M-15 C 114 IPM, DOR, MEM, TGC, FOF 128 128
P31 EcP32 20/12/2012 Urines CTX-M-15 Ø 97 IPM, DOR, MEM, AMK, FOF 256 512
P32 EcP33 18/02/2013 Stool CTX-M-15 Ø 78 IPM, DOR, MEM, AMK, FOF >512 >512
P33 EcP34 24/03/2013 Stool ND Ø NEW IPM, DOR, MEM, KAN,
TOB, AMK, GEN, NET, CIP,
FOF
ND ND
P34 EcP35 10/05/2013 Stool CTX-M-9/SHV-12 B 133 IPM, DOR, MEM, FOF ND ND
P35 EcP36 13/06/2013 Stool CTX-M-15 C 114 IPM, DOR, MEM, AMK,
TGC, FOF
ND ND
P36 EcP37 24/06/2013 Urines SHV-12 Ø 106 IPM, DOR, MEM, AMK, FOF ND ND
P37 EcP38 01/07/2013 Throat CTX-M-15 C 114 IPM, DOR, MEM, AMK,
TGC, FOF
ND ND
P38 EcP39 15/07/2013 Throat CTX-M-15 C 114 IPM, DOR, MEM, AMK, FOF ND ND
P39 EcP40 08/08/2013 Stool CTX-M-9/SHV-12 D 50 IPM, DOR, MEM, AMK,
OFX, CIP, TGC, FOF
ND ND
(Continued)
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TABLE 1 | Continued
Patient
number
Strain Date of first
isolation
(dd/mm/yyyy)
Source
of first
isolation
ESBL PFGE
pulsotypea
ST Active antibioticsb ADBAC
MIC
(mg/l)
DDAC
MIC
(mg/l)
P40 EcP41 23/09/2013 Stool CTX-M-15 C 114 IPM, DOR, MEM, TGC, FOF ND ND
P41 EcP42 17/10/2013 Stool ND Ø 145 IPM, DOR, MEM, AMK,
GEN, NET, OFX, CIP, TGC,
SXT, FOF
ND ND
P42 EcP43 16/12/2013 Stool CTX-M-15 F 66 IPM, DOR, MEM, AMK, FOF ND ND
P43 EcP44 12/12/2013 Stool CTX-M-15 F 66 IPM, DOR, MEM ND ND
aLetters identify the different pulsotypes. A pulsotype that was recovered only once is reported by “Ø”.
bAMK, amikacin; CIP, ciprofloxacin; FOF, fosfomycin; GEN, gentamicin; IPM, imipenem; KAN, kanamycin; NET, netilmicin; OFX, ofloxacin; TGC, tigecycline; TOB, tobramycin; SXT,
trimethoprim-sulfamethoxazole.
ND, not determined.
TABLE 2 | Characteristics of ESBL-producing Enterobacter cloacae isolated from the environment of patients hospitalized in the Hematology ward.
Source Sample Strain PFGE pulsotypea ST ESBL ADBAC MIC (mg/l) DDAC MIC (mg/l)
PROTECTED AREA
Room 19 Patient sink drain EcE1 F 66 CTX-M-15 128 128
CONVENTIONAL AREA
Room 34 Medical sink drain EcE2 C 114 CTX-M-15 ND ND
Patient sink drain EcE3 C 114 CTX-M-15 ND ND
Shower drain EcE4 C 114 CTX-M-15 256 128
EcE5 Cb 114 CTX-M-15 128 128
Room 36 Medical sink drain EcE6 B 133 CTX-M-9/SHV-12 256 128
Shower drain EcE7 A 110 CTX-M-9/SHV-12 512 512
Room 37 Shower drain EcE8 D 50 CTX-M-9/SHV-12 512 512
Room 38 Patient sink drain EcE9 F 66 CTX-M-15 128 128
Shower drain EcE10 Ø 50 CTX-M-9/CTX-M-15/SHV-12 128 64
Room 40 Shower drain EcE11 E 110 CTX-M-9/SHV-12 128 128
Room 46 Shower drain EcE12 F 66 CTX-M-15 128 64
EcE13 C 114 CTX-M-15 128 128
Room 48 Shower drain EcE14 E 110 CTX-M-9/SHV-12 256 256
Room 64 Shower drain EcE15 C 114 CTX-M-15 128 128
Room 65 Shower drain EcE16 Ø 78 CTX-M-15 128 64
EcE17 Ø NEW CTX-M-9/SHV-12 256 128
aLetters identify the different pulsotypes. A pulsotype that was recovered only once is reported by “Ø”. Pulsotypes in bold were identical to clinical strain pulsotypes.
b Isolate resistant to carbapenems.
ND, not determined.
shower drain produced three ESBL: SHV-12, CTX-M-9, and
CTX-M-15 and was genetically unrelated.
Susceptibility Testing
All clinical isolates were resistant to all beta-lactams with the
exception of carbapenems. Amikacin remained active in most
cases (73%) as well as fosfomycin (89%). Only 25% of the
isolates were susceptible to tigecyclin and 20% to ciprofloxacin.
The MICs of ADBAC and DDAC were very high for clinical
and environmental isolates, ranging from 64 to > 512 mg/l.
The MICs of ADBAC and DDAC for the four reference
strains were respectively 2 and 1 mg/l for S. aureus CIP 483
32, and 8 mg/l for E. coli CIP 54127, 64 and 64 mg/l for
E. cloacae CIP 6085, 512 and 512 mg/l for P. aeruginosa CIP
103467.
DISCUSSION
Our investigations started when we observed that the number of
patients with ESBL-producing E. cloacae increased dramatically
since August 2012. Indeed 17 new patients were concerned
between August and December 2012.
It is noteworthy that many isolates were identified as ST114 or
as ST66. In a very recent study these STs that belong to the same
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FIGURE 1 | Epicurve with all samples of E. cloacae for newly infected or colonized patients between January 2011 and December 2013. Numbers in
parenthesis are the numbers of newly hospitalized patients in the Hematology ward each month. Black arrow: implementation of the bleach-based disinfection
programme after complete cleaning of the sink.
apparent clonal complex CC114 (Izdebski et al., 2015) have been
described as prevalent and widespread. Indeed they have been
detected from rectal swabs in several hospital units across Europe
(France, Italy, Spain, Greece) but also Israel. The biological
success of these clones has to be confirmed by undertakingMLST
analysis of a large number of isolates from different areas.
The genotypic diversity of our clinical isolates did not suggest
a single common exogenous source of infection as already
noticed in previous studies about outbreaks of P. aeruginosa
linked with environmental contamination (Inglis et al., 2010).
Moreover, the observation of the practices of health-care workers
revealed that they complied with the infection control measures.
This prompted us to conduct investigation in the patient care
environment. Surprisingly ESBL-producing E. cloacae have been
detected in 10 patients rooms, meaning an environmental
contamination of nearly half of the total ward. Positive samples
concerned only the sink drains (medical sink drains, patient
sink drains, and shower drains). In these sites we observed the
presence of biofilm. We did not detect any ESBL-producing
E. cloacae on wet surfaces or in the water. That is not in accord
with other reports (Gbaguidi-Haore et al., 2013; Judge et al.,
2013). For instance in the study of Judge et al., the culture of
4 out of 18 wet sites surrounding patients colonized by ESBL-
producing K. pneumoniae were positive with the same organism
(Judge et al., 2013). Most of the descriptions of outbreaks due
to ESBL-producing E. cloacae report characterization of the
clinical isolates but environmental sampling of wet sites around
the patient are rarely performed (Dalben et al., 2008; Kruse
et al., 2010). Nevertheless, two interesting studies compared
environmental and clinical isolates belonging mostly to other
species. In the first one Lowe et al. reported an outbreak
of ESBL-producing Klebsiella oxytoca concerning 66 patients
and demonstrated that the sink drains were reservoirs. The
outbreak stopped after sink drain modification (Lowe et al.,
2012). In the second one comparing 62 environmental strains
belonging to 4 species of ESBL-producing Enterobacteriaceae
with 43 clinical isolates, the authors identified 4 identical
patterns (3 K. oxytoca and 1 E. cloacae) between clinical
and environmental strains recovered from wet sites including
sink drains (Kac et al., 2004). Our findings confirm that sink
drains have to be considered as important potential reservoirs
of ESBL-producing strains. This has been also pointed out
in the study of Roux et al. that reported the contamination
by ESBL-producing Enterobacteriaceae of 57 sinks among the
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185 that were sampled (Roux et al., 2013). Interestingly these
producers were mainly K. pneumoniae but also E. cloacae
(respectively 33 and 18). Unfortunately the study did not
report comparison of these environmental strains with clinical
isolates.
The transfer of pathogens from sink to patients may occur
in several situations resulting from a splash-back that leads to
contamination of an area that can reach at least 1m from the sink
(Hota et al., 2009). Therefore, the patient can be contaminated
during teeth brushing or hands washing or showering. The
health-care workers are also at risk of hand contamination
leading possibly to transfer the pathogen to the patients during
care. The phenomenon is amplified when the water flows directly
into the sink drain as we observed in nearly all patients rooms.
This is considered as inadequate sink design (Breathnach et al.,
2012). The mode of contamination is difficult to establish for
most of our patients mainly because of hospital stays in different
rooms. Nevertheless, for 4 of them the correlation between their
colonization/infection and their stay in a contaminated roomwas
easy to perform (Figure 2).
The first one (P22) was in room 32 from 16th to 31st October
2012. All samples from stool and throat were negative (each
performed 4 times). He has been transferred in the protected
area in the room 19 (1st of November) and had twice negative
samples. An ESBL-producing E. cloacae has been detected in his
stool on the 8th of November. This isolate belonged to pulsotype
F as the one from the sink drain of room 19 suggesting that
the contamination occurred there. The second one (P25) had 4
hospital stays between the 21st June 2012 and the 29th September
2012 for a total of 69 days. During this period he had 17 negative
samples. Between the 16th October and the 30th November he
was successively in rooms 38, 64, and 30. On the 26th November
2012 he had a positive stool sample that harbored the pulsotype
F as the one from the sink drain of room 38. The third one (P27)
had 7 hospital stays between the 2nd April 2012 and the 3rd
December 2012 in different rooms with 23 negative samples. He
was transferred in room 38 on the 4th December and we detected
an ESBL-producing E. cloacae in his throat only 2 days later. In
this case the contamination occurred probably while brushing his
teeth. For the fourth patient (P26) the series of events is easier.
FIGURE 2 | Plan of the Hematology ward. Numbers indicate room numbers. ESBL-producing E. cloacae were isolated from samples collected in gray rooms.
Patient number contaminated by sink is indicated in the occurring room.
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He arrived at hospital on the 21st November 2012. The same
day a PICC-line catheter was positioned. He stayed in room 46
and had twice negative samples (22nd and 26th November). On
the 28th November he developed a sepsis and blood cultures
were positive with ESBL-producing E. cloacae that belonged to
pulsotype F as the one recovered in the shower drain in room
46. The contamination of this patient probably occurred while
he took a shower. At this occasion splash-back from the drain
might have transfer the pathogen to the dressing of the catheter
inducing then a sepsis for which he had to be transferred in ICU.
All these findings and the fact that substantial fall in cases
number has been observed after complete cleaning of the
sinks in the ward indicated that they were very important
reservoirs. Nevertheless, a last question rose: why E. cloacae
isolates belonging to various pulsotypes were so widespread?
It is well established that organisms are able to survive in
biofilm (Khan et al., 2012; Vergara-López et al., 2013). MICs of
ADBAC and DDAC were very high for all isolates of E. cloacae
included whatever their beta-lactam resistance phenotype: ESBL,
overexpression of AmpC, wild-type but also the reference
strain. These very first data about the efficacy of the QACs on
E. cloacae suggested that this species might be intrinsically poorly
susceptible to these compounds. The genetic determinants of this
resistance remain to be explored, especially the presence of eﬄux
pump genes as already described for E. coli and K. pneumoniae
(Abuzaid et al., 2012; Buffet-Bataillon et al., 2012).
In the Hematology ward the disinfectant poured daily into all
sinks was at the recommended concentration of 0.25% (or 2500
mg/l). Given that the sinks were covered with biofilm and that
the time of contact of that biofilm to the disinfectant was short
the organisms present in the sinks were exposed to subinhibitory
concentrations and survived despite the frequent disinfection.
In a previous study it was demonstrated that QAC resistance
could be enhanced through exposure of the sensitive bacteria
to increasing concentrations of QACs (Sidhu et al., 2002). The
disinfection program implemented in December 2012 included
biofilm removal from all sinks and use of a bleach solution
daily. These measures were efficient: only three new cases
occurred between January and May 2013. After June 2013 we
observed a new minor increase of the number of cases. The sinks
are not accessible without complete dismantling and therefore
their complete cleaning was not performed again, leading to
the formation of new biofilm and to the risk of persistence
of dangerous reservoirs. The susceptibility to disinfectants of
diverse multiresistant nosocomial pathogens might be tested by
the manufacturers to provide the best information to the users.
In conclusion, in this study we have demonstrated that
the large outbreak of ESBL-producing E. cloacae concerning
43 patients from the Hematology ward was associated with
the contamination of many sinks of the unit by isolates with
decreased susceptibility to QACs. It is necessary to keep in mind
that all components of hospital environment are important in the
prevention of healthcare-associated infections and this includes
the choice of accessible sinks to allow a periodic cleaning with
efficient disinfectant. “Primum non nocere” is a guiding principle
for physicians but should be also a guiding principle for hospital
designers.
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